Leading Chinese CRO WuXi PharmaTech Aims To Ensure Rebound After 2008's Massive Loss With Launch Of New Toxicology Center
This article was originally published in PharmAsia News
Executive Summary
BEIJING - To solidify a recovery after posting a massive loss for last year, WuXi PharmaTech is pumping funds into a new drug safety testing center and state-of-the-art manufacturing facility along the economically dynamic East coast of China